Cytomegalovirus Seropositivity Is Associated with Increased Arterial Stiffness in Patients with Chronic Kidney Disease
暂无分享,去创建一个
P. Moss | J. Townend | R. Steeds | C. Ferro | L. Harper | C. Chue | N. Edwards | S. Lauder | T. Pankhurst | Nadezhda A Wall | Nadezhda Wall
[1] A. Sharrett,et al. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. , 2012, The Journal of infectious diseases.
[2] T. Lehtimäki,et al. Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow‐mediated dilation in young men: the Cardiovascular Risk in Young Finns Study , 2012, Clinical and experimental immunology.
[3] Xueqing Yu,et al. Signature microRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection , 2011, Circulation.
[4] P. Caposio,et al. The role of cytomegalovirus in angiogenesis. , 2011, Virus Research.
[5] F. Baas,et al. Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. , 2010, The Journal of clinical investigation.
[6] M. Cannon,et al. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection , 2010, Reviews in medical virology.
[7] Tracy R. Keeney,et al. Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.
[8] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[9] J. Townend,et al. Arterial stiffness in chronic kidney disease: causes and consequences , 2010, Heart.
[10] P. Sedgwick. Matching , 2009, BMJ : British Medical Journal.
[11] J. Townend,et al. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. , 2009, Journal of the American College of Cardiology.
[12] C. Crumpacker,et al. Cytomegalovirus Infection Causes an Increase of Arterial Blood Pressure , 2009, PLoS pathogens.
[13] G. Dolivet,et al. Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[14] De⁃xin Wang,et al. Detection of human cytomegalovirus in atherosclerotic carotid arteries in humans. , 2008, Journal of the Formosan Medical Association = Taiwan yi zhi.
[15] V. Bellizzi,et al. [Prevalence of chronic kidney disease]. , 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.
[16] A. Steptoe,et al. Socioeconomic status and cardiovascular disease risk - The authors' reply , 2008 .
[17] A. Steptoe,et al. The authors' reply: , 2008, Heart.
[18] J. Mieczkowska,et al. Socioeconomic status and cardiovascular disease risk , 2008, Heart.
[19] J. Deanfield,et al. Endothelial Dysfunction and Cytomegalovirus Replication in Pediatric Heart Transplantation , 2008, Circulation.
[20] J. Connell,et al. Aortic Stiffness and Diastolic Flow Abnormalities in End-Stage Renal Disease Assessed by Magnetic Resonance Imaging , 2008, Nephron Clinical Practice.
[21] J. Coresh,et al. Prevalence of chronic kidney disease in the United States. , 2007, JAMA.
[22] M. Majesky. Developmental basis of vascular smooth muscle diversity. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[23] B. Henderson,et al. Socioeconomic status, pathogen burden and cardiovascular disease risk , 2006, Heart.
[24] H. Struijker‐Boudier,et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.
[25] J. Townend,et al. The treatment of coronary artery disease in patients with chronic kidney disease. , 2006, QJM : monthly journal of the Association of Physicians.
[26] B. Narasimhan,et al. Acute Rejection and Cardiac Allograft Vascular Disease Is Reduced by Suppression of Subclinical Cytomegalovirus Infection , 2006, Transplantation.
[27] M. Yoshizumi,et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. , 2005, Journal of the American College of Cardiology.
[28] G. Ridgway,et al. Human Cytomegalovirus Seropositivity Is Associated With Impaired Vascular Function , 2003, Circulation.
[29] J. Brophy,et al. Absence of Association Between Infectious Agents and Endothelial Function in Healthy Young Men , 2003, Circulation.
[30] S. Yusuf,et al. Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study , 2003, Circulation.
[31] D. Levy,et al. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. , 2002, Journal of the American College of Cardiology.
[32] S. Blankenberg,et al. Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection? , 2000, Stroke.
[33] A. Folsom,et al. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. , 2000, Archives of internal medicine.
[34] Jianhui Zhu,et al. Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.
[35] A de Roos,et al. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. , 1998, The American journal of cardiology.
[36] H. Miller,et al. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. , 1998, The American journal of cardiology.
[37] M. Daemen,et al. Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: a study in rat. , 1997, Cardiovascular research.
[38] P. Sorlie,et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. , 1996, Circulation.
[39] D G Altman,et al. Statistics notes: Matching , 1994 .
[40] T. Merigan,et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. , 1992, The New England journal of medicine.
[41] C. Bruggeman,et al. Infection and atherosclerosis. An alternative view on an outdated hypothesis. , 2008, Pharmacological reports : PR.
[42] J. Lin,et al. Detection of human cytomegalovirus in the atherosclerotic cerebral arteries in Han population in China. , 2008, Acta virologica.
[43] M. Yoshizumi,et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. , 2005, Journal of the American College of Cardiology.
[44] G. Vetrovec,et al. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. , 1998, The Journal of infectious diseases.